Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$84.27
-2.78%
Mkt Cap $7.25B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $15.05M | $2.87M | -80.92% | -$0.78 | -$0.97 | -23.78% | — | — |
| Q4 2025 Nov 4, 2025 | $14.45M | $2.76M | -80.87% | -$0.71 | -$0.90 | -26.76% | — | — |
| Q3 2025 Aug 11, 2025 | $17.13M | $11.48M | -33.01% | -$0.83 | -$0.95 | -14.46% | — | — |
| Q2 2025 May 9, 2025 | $12.38M | $22.10M | +78.49% | -$0.92 | -$0.82 | +10.87% | — | — |
| Q1 2025 Feb 27, 2025 | $16.68M | $7.39M | -55.67% | -$0.76 | -$0.88 | -15.79% | — | — |
| Q4 2024 Oct 31, 2024 | $15.21M | $3.74M | -75.41% | -$0.83 | -$0.82 | +1.20% | — | — |
| Q3 2024 Aug 7, 2024 | $12.55M | $25.65M | +104.38% | -$0.69 | -$0.58 | +15.94% | — | — |
| Q2 2024 May 2, 2024 | $13.69M | $10.29M | -24.86% | -$0.73 | -$0.69 | +5.48% | — | — |
| Q1 2024 Feb 22, 2024 | $41.96M | $47.88M | +14.12% | -$0.44 | -$0.25 | +43.18% | — | — |
| Q4 2023 Nov 2, 2023 | $15.97M | $4.73M | -70.39% | -$0.73 | -$0.90 | -23.29% | — | — |
| Q3 2023 Aug 3, 2023 | $14.06M | $16.51M | +17.45% | -$0.70 | -$0.67 | +4.29% | — | — |
| Q2 2023 May 4, 2023 | $14.15M | $9.47M | -33.10% | -$0.69 | -$0.70 | -1.45% | — | — |
| Q1 2023 Feb 23, 2023 | $22.05M | $16.14M | -26.82% | -$0.57 | -$0.60 | -5.26% | — | — |
| Q4 2022 Nov 3, 2022 | $15.51M | $9.55M | -38.43% | -$0.70 | -$0.79 | -12.86% | — | — |
| Q3 2022 Aug 9, 2022 | $14.24M | $11.51M | -19.13% | -$0.68 | -$0.78 | -14.71% | — | — |
| Q2 2022 May 3, 2022 | $18.75M | $9.62M | -48.67% | -$0.67 | -$0.71 | -5.97% | — | — |
| Q1 2022 Feb 24, 2022 | $21.31M | $15.28M | -28.33% | -$0.36 | -$0.66 | -83.33% | — | — |
| Q4 2021 Nov 10, 2021 | $17.76M | $20.34M | +14.48% | -$0.34 | -$0.56 | -64.71% | — | — |
| Q3 2021 Aug 6, 2021 | $18.52M | $18.52M | +0.00% | -$0.21 | -$0.55 | -161.90% | — | — |
| Q2 2021 May 6, 2021 | $15.62M | $18.70M | +19.72% | -$0.17 | -$0.29 | -70.59% | — | — |